1. Home
  2. DRMA vs ABTS Comparison

DRMA vs ABTS Comparison

Compare DRMA & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • ABTS
  • Stock Information
  • Founded
  • DRMA 2014
  • ABTS 2010
  • Country
  • DRMA United States
  • ABTS Hong Kong
  • Employees
  • DRMA N/A
  • ABTS N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • ABTS Computer Software: Programming Data Processing
  • Sector
  • DRMA Health Care
  • ABTS Technology
  • Exchange
  • DRMA Nasdaq
  • ABTS Nasdaq
  • Market Cap
  • DRMA 4.5M
  • ABTS 4.6M
  • IPO Year
  • DRMA 2021
  • ABTS N/A
  • Fundamental
  • Price
  • DRMA $0.82
  • ABTS $2.51
  • Analyst Decision
  • DRMA Strong Buy
  • ABTS
  • Analyst Count
  • DRMA 1
  • ABTS 0
  • Target Price
  • DRMA $6.00
  • ABTS N/A
  • AVG Volume (30 Days)
  • DRMA 282.9K
  • ABTS 30.6K
  • Earning Date
  • DRMA 05-19-2025
  • ABTS 12-31-2024
  • Dividend Yield
  • DRMA N/A
  • ABTS N/A
  • EPS Growth
  • DRMA N/A
  • ABTS N/A
  • EPS
  • DRMA N/A
  • ABTS N/A
  • Revenue
  • DRMA N/A
  • ABTS $6,711,225.00
  • Revenue This Year
  • DRMA N/A
  • ABTS N/A
  • Revenue Next Year
  • DRMA N/A
  • ABTS N/A
  • P/E Ratio
  • DRMA N/A
  • ABTS N/A
  • Revenue Growth
  • DRMA N/A
  • ABTS 299.11
  • 52 Week Low
  • DRMA $0.69
  • ABTS $0.25
  • 52 Week High
  • DRMA $6.17
  • ABTS $4.19
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 43.16
  • ABTS 49.38
  • Support Level
  • DRMA $0.73
  • ABTS $2.28
  • Resistance Level
  • DRMA $0.99
  • ABTS $3.10
  • Average True Range (ATR)
  • DRMA 0.08
  • ABTS 0.44
  • MACD
  • DRMA 0.02
  • ABTS -0.03
  • Stochastic Oscillator
  • DRMA 34.93
  • ABTS 38.64

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations.

Share on Social Networks: